Navigation Links
FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager
Date:4/25/2008

AX Series Delivers MyFluVaccine Portal a Next-generation Server Load

Balancer Platform for Web Application Delivery

SAN JOSE, Calif., April 25 /PRNewswire/ -- A10 Networks(R) today announced that FFF Enterprises, the nation's largest distributor of plasma products, vaccines and other biopharmaceuticals, selected and deployed A10's AX Series Advanced Traffic Manager to provide a Web application delivery platform for its MyFluVaccine(TM) portal. MyFluVaccine,(TM) delivered by FFF Enterprises, is the nation's first online vaccine portal, allowing vaccine providers to order a dedicated supply of vaccines for guaranteed delivery on the dates they choose. FFF Enterprises selected A10's AX Series to load balance its Web servers, especially during peak usage conditions, to ensure the MyFluVaccine portal is always available and performing as desired for its customers.

To prepare for the peak flu vaccine ordering season, FFF enterprises began evaluating Juniper's DX line of server load balancers. However, shortly after the initial evaluation, Juniper announced it will end of life its DX family with a smooth transition for customers. FFF Enterprises concurrently read about A10's AX Series Advanced Traffic Manager family in the news, highlighting recent independent third-party performance tests from the Tolly Group, which proved that AX delivers over double the performance at less than half the price of incumbents. As a result, FFF Enterprises chose to evaluate the AX Series.

"We found the AX Series at the perfect time. After reading positive stories about its price/performance advantage over incumbents we tested the AX in our environment and discovered that the claims we read were true," said Bob Coates, VP of Technology for FFF Enterprises. "A10's AX Series provides us with a high-performance server load balancer solution to ensure MyFluVaccine(TM) is always performing and available."

The key AX Series features that FFF Enterprises leverages include Layer 4-7 server load balancing, SSL acceleration/offload to increase Web transaction speed and application persistence to ensure a positive experience for customers placing orders on the portal. FFF Enterprises also leverages AX's high-performance aRule(TM) advanced scripting to customize policies to manipulate Layer 7 traffic and avoid traffic bottlenecks.

Additional key features within the AX Series include:

-- Revolutionary Advanced Core Operating System (ACOS):

-- Leverages modern system architectures

-- Tuned for multiple-core CPUs

-- Industry's best SSL and Layer 4-7 performance, at the most

cost-effective price

-- Carrier-grade hardware components and redundancy

"We are proud to provide FFF Enterprises the superior Web Application Delivery platform it requires while running its industry-leading MyFluVaccine(TM) portal," said Lee Chen, founder and CEO of A10 Networks. "The AX Series achieves high performance in a small footprint that delivers a significant price advantage for the Web Application Delivery market."

Advanced Core Operating System (ACOS): Optimized Multi-CPU Architecture

The Advanced Core Operating System (ACOS) -- built by A10's team of industry-leading engineers with high performance Layer 2-3, Layer 4-7 and super computing expertise -- is the distinguishing technology that makes the AX Series stand out in the Web application delivery market. Many of the incumbent vendors' solutions are based on legacy architecture not designed to address the greater scale of Internet traffic and security requirements -- for today and tomorrow. In order to address the need for speed, vendors continue to move their single-CPU software solutions to more powerful multi-CPU traffic management systems. But without the complete redesign of the software, performance benefits as a result of more powerful hardware will never be realized.

A10's AX Series with ACOS includes an optimized, multi-CPU architecture, built from the ground up. ACOS provides the ability to linearly and concurrently scale processing resources. By evenly distributing application traffic to the system's processors, ACOS eliminates performance bottlenecks caused by unevenly loaded processors -- allowing applications to perform as desired, especially during peak usage conditions.

To read the full case study, please visit: http://www.a10networks.com/resources/files/CS-FFF.pdf

About A10 Networks

A10 Networks was founded in Q4 2004 with a mission to provide innovative networking and security solutions. A10 Networks makes high-performance products that help organizations accelerate, optimize and secure their applications. A10 Networks is headquartered in Silicon Valley with offices in the United States, Japan, China, Korea and Taiwan. For more information, visit http://www.a10networks.com.

About FFF Enterprises

Founded in 1988, FFF Enterprises is a multidimensional healthcare company, delivering innovative solutions in biopharmaceutical management and distribution, managed healthcare services, health information management and consumer healthcare services. FFF's influenza vaccine innovation, MyFluVaccine.com, launched in 2006, revolutionized the influenza vaccine marketplace, allowing healthcare providers to select their influenza vaccine delivery dates -- bringing trust to the marketplace.

For more information about FFF Enterprises and MyFluVaccine, visit http://www.fffenterprises.com or call 800-843-7477.


'/>"/>
SOURCE A10 Networks
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems
2. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
3. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
4. Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China
5. CJPS Enterprises Spins Off New Company for Intellectual Property Marketing
6. Nu Skin Enterprises Announces Increase in Quarterly Dividend
7. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
8. Nu Skin Enterprises to Present at Bank of America 2008 Consumer Conference
9. CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline
10. Nu Skin Enterprises to Announce First Quarter 2008 Results
11. CJPS Enterprises Announces a Series of Seminars on Automotive Diversification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... 2016 , ... After a year and a half of planning the Multiple Pathways of ... Multiple Pathways of Recovery Conference was held May 2 -4, 2016 at the Mystic ... came together to explore the many pathways individuals use to get into and sustain their ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue ... Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields ... Director of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health ...
(Date:5/27/2016)... ... , ... This campaign aims to provide a path to improved education and ... and change. , As nearly 795,000 Americans suffering from a new or recurrent stoke ... with an estimated 129,000 of these people dying from stroke, it’s become our nation’s ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the ... for an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center ... Market Committee (FOMC) dot charts are of interest to the press for their noise ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... PUNE, India , May 27, 2016 ... in the instances of hypertension is driving ambulatory blood ... muscles lose their elasticity and their ability to respond ... blood pressure. This condition can lead to various cardiovascular ... and peripheral vascular disease. These diseases are growing in ...
(Date:5/26/2016)... , May 26, 2016 According ... "Medical Waste Management Market - U.S. Industry Analysis, Size, Share, ... management market in the U.S. was valued at US$ 5.89 ... CAGR of 3.4% from 2015 to 2023 to reach US$ ... analysis of current and emerging needle free drug delivery devices ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
Breaking Medicine Technology: